Operating Lease, Right-of-Use Asset of Mural Oncology plc from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Mural Oncology plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
Mural Oncology plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,134,000, a 64% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Mural Oncology plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$3,134,000	-$5,499,000	-64%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$4,361,000	-$5,765,000	-57%	30 Jun 2025	10-Q	04 Aug 2025	2025	Q2
Q1 2025	$5,577,000	-$5,841,000	-51%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$6,783,000	-$5,964,000	-47%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$8,633,000	-$5,520,000	-39%	30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$10,126,000			30 Jun 2024	10-Q	13 Aug 2024	2024	Q2
Q1 2024	$11,418,000			31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$12,747,000	-$5,569,000	-30%	31 Dec 2023	10-K	11 Mar 2025	2024	FY
Q3 2023	$14,153,000			30 Sep 2023	10-Q	14 Dec 2023	2023	Q3
Q4 2022	$18,316,000			31 Dec 2022	10-K	26 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.